Cheng H - Search Results

1

Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.

Ray MR, Wafa LA, Cheng H, Snoek R, Fazli L, Gleave M, Rennie PS. Ray MR, et al. Among authors: cheng h. Int J Cancer. 2006 Mar 1;118(5):1108-19. doi: 10.1002/ijc.21469. Int J Cancer. 2006. PMID: 16161052

2

Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.

Wafa LA, Cheng H, Rao MA, Nelson CC, Cox M, Hirst M, Sadowski I, Rennie PS. Wafa LA, et al. Among authors: cheng h. Biochem J. 2003 Oct 15;375(Pt 2):373-83. doi: 10.1042/BJ20030689. Biochem J. 2003. PMID: 12864730 Free PMC article.

3

Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression.

Cheng H, Snoek R, Ghaidi F, Cox ME, Rennie PS. Cheng H, et al. Cancer Res. 2006 Nov 1;66(21):10613-20. doi: 10.1158/0008-5472.CAN-06-0028. Cancer Res. 2006. PMID: 17079486

4

Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.

Margiotti K, Wafa LA, Cheng H, Novelli G, Nelson CC, Rennie PS. Margiotti K, et al. Among authors: cheng h. Mol Cancer. 2007 Jun 6;6:38. doi: 10.1186/1476-4598-6-38. Mol Cancer. 2007. PMID: 17553164 Free PMC article.

5

In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors.

Snoek R, Cheng H, Margiotti K, Wafa LA, Wong CA, Wong EC, Fazli L, Nelson CC, Gleave ME, Rennie PS. Snoek R, et al. Among authors: cheng h. Clin Cancer Res. 2009 Jan 1;15(1):39-47. doi: 10.1158/1078-0432.CCR-08-1726. Clin Cancer Res. 2009. PMID: 19118031

6

TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains.

Tavassoli P, Wafa LA, Cheng H, Zoubeidi A, Fazli L, Gleave M, Snoek R, Rennie PS. Tavassoli P, et al. Among authors: cheng h. Mol Endocrinol. 2010 Apr;24(4):696-708. doi: 10.1210/me.2009-0229. Epub 2010 Feb 24. Mol Endocrinol. 2010. PMID: 20181722 Free PMC article.

7

Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression.

Wafa LA, Cheng H, Plaa N, Ghaidi F, Fukumoto T, Fazli L, Gleave ME, Cox ME, Rennie PS. Wafa LA, et al. Among authors: cheng h. Int J Cancer. 2012 Jun 15;130(12):2835-44. doi: 10.1002/ijc.26287. Epub 2011 Sep 14. Int J Cancer. 2012. PMID: 21780103

8

In vitro and in vivo silencing of the androgen receptor.

Cheng H, Leblanc E, Rennie PS. Cheng H, et al. Methods Mol Biol. 2011;776:95-112. doi: 10.1007/978-1-61779-243-4_7. Methods Mol Biol. 2011. PMID: 21796523

9

Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.

Thomas C, Wafa LA, Lamoureux F, Cheng H, Fazli L, Gleave ME, Rennie PS. Thomas C, et al. Among authors: cheng h. Prostate. 2012 Jun 1;72(8):875-85. doi: 10.1002/pros.21490. Epub 2011 Oct 5. Prostate. 2012. PMID: 22072572

10

The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors.

Xie N, Cheng H, Lin D, Liu L, Yang O, Jia L, Fazli L, Gleave ME, Wang Y, Rennie P, Dong X. Xie N, et al. Among authors: cheng h. Int J Cancer. 2015 Feb 15;136(4):E27-38. doi: 10.1002/ijc.29147. Epub 2014 Aug 27. Int J Cancer. 2015. PMID: 25138562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,683 results

Search Page

Filters